Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Demega Formulations is an Indian pharmaceutical company headquartered in Mumbai, specializing in the manufacturing, exporting, and supplying of a diverse range of generic pharmaceutical products. The company focuses on providing affordable access to essential medicines across therapeutic categories such as oncology, virology (including HIV and Hepatitis), and men's health. Demega operates as a significant player in the global generic export market, catering to clients in various international regions including Africa, Southeast Asia, and the Middle East. Their portfolio encompasses a variety of dosage forms, including oral solids and injectables, produced under stringent quality control standards. The company is recognized for its commitment to making high-cost treatments more accessible through the distribution of high-quality generic alternatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Demega Formulations.